IL1RL1 and asthma: In a mouse model of asthma induced by prolonged HDM, targeting IL-33 using a neutralizing antibody normalised established eosinophilic, neutrophilic, and ST2+CD4+ T-cell infiltration and improved remodeling of both the lung epithelium and parenchyma (146).